In leukemia patients with NPM1c, or rearrangements in KMT2A and NUP98, a number of these regulators are considered instrumental for loss of transcriptional control and aberrant expression of HOXA/B/MEIS1, and other leukemia-associated target genes. This evidence concerns the gene KMT2A and leukemia.